Cargando…

Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma

SIMPLE SUMMARY: The active disease status of patients with a malignant germ cell tumor can be evaluated using detection of specific body-circulating microRNAs. However, various methods are reported to isolate and detect microRNAs from blood, possibly influencing the score as positive or negative. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmerman, Dennis M., Gillis, Ad J. M., Mego, Michal, Looijenga, Leendert H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428229/ https://www.ncbi.nlm.nih.gov/pubmed/34503070 http://dx.doi.org/10.3390/cancers13174260

Ejemplares similares

Clinical utility of plasma miR‐371a‐3p in germ cell tumors
por: Mego, Michal, et al.
Publicado: (2018)

The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
por: Salvatori, Daniela C.F., et al.
Publicado: (2018)

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
por: Spiller, Cassy M., et al.
Publicado: (2020)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
por: Lobo, João, et al.
Publicado: (2021)

Cellular origin of microRNA‐371a‐3p in healthy males based on systematic urogenital tract tissue evaluation
por: Boellaard, W. P. A., et al.
Publicado: (2019)

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
por: Lobo, João, et al.
Publicado: (2019)

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
por: Murray, Matthew J, et al.
Publicado: (2016)

Serum microRNA profiles in athyroid patients on and off levothyroxine therapy
por: Massolt, Elske T., et al.
Publicado: (2018)

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
por: van Agthoven, Ton, et al.
Publicado: (2016)

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2022)

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
por: Nestler, Tim, et al.
Publicado: (2023)

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
por: Dieckmann, K-P, et al.
Publicado: (2012)

MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers
por: Pan, Bei, et al.
Publicado: (2019)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
por: Radtke, A., et al.
Publicado: (2017)

MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2016)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020)

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection
por: Loehr, Amanda R., et al.
Publicado: (2023)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2018)

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
por: Rosas Plaza, Ximena, et al.
Publicado: (2019)

Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human
por: Krauskopf, Julian, et al.
Publicado: (2017)

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
por: Lobo, João, et al.
Publicado: (2019)

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020)

Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
por: Belge, Gazanfer, et al.
Publicado: (2020)

PSAT371 Thyroid Ultrasound, Biopsy and Cancer in a US Veteran Population
por: Arif, Azka, et al.
Publicado: (2022)

VASA mRNA (DDX4) detection is more specific than immunohistochemistry using poly- or monoclonal antibodies for germ cells in the male urogenital tract
por: Boellaard, Willem P.A., et al.
Publicado: (2017)

Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma
por: Wang, Shuo, et al.
Publicado: (2020)

The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies
por: Quirico, Lorena, et al.
Publicado: (2020)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours
por: de Boer, Carmela M, et al.
Publicado: (2012)

Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines
por: Eini, Ronak, et al.
Publicado: (2014)

CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery
por: Daddali, Ravindra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tnqnffrfb3ekqvg6n2b7b9kog